Form D · Other Health Care
Protego Biopharma, Inc.
San Diego, CA · CIK 0001796909
Offering snapshot reported Dec 3, 2025 · SEC filing
- Reported sold
- $32.9M Offering amount: $130M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 17, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 3, 2025 | Initial | $32,942,190 | No comparison | 18 | SEC filing |
| Oct 28, 2021 | Initial | $51,047,342 | No comparison | 6 | SEC filing |
| Dec 17, 2019 | Initial | $1,000,012 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-565675
Source: Form D, filed Dec 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Saoussen Ben Halima | Director |
| Laura Brass | Director |
| Shelley Chu | Director |
| Edward Hurwitz | Director |
| Xin Jiang | Executive |
| Jeffrey Kelly | Director |
| Jeffery Kelly | Director |
| Helen Kim | Director |
| Richard Labaudiniere | Director, Executive |
| Tim Lohoff | Director |
| Janwillem Naesens | Director |
| Hank Michael Petrassi | Executive |
| Brent J. Warner | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
10945 Vista Sorrento Parkway, Suite 150
San Diego, CA, 92130
San Diego, CA, 92130